Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • Publication Information:
      Public Library of Science (PLoS), 2018.
    • Publication Date:
      2018
    • Collection:
      LCC:Medicine
      LCC:Science
    • Abstract:
      To test the ability of four circulating biomarkers of fibrosis, and of low left atrial voltage, to predict recurrence of atrial fibrillation after catheter ablation.Circulating biomarkers potentially may be used to improve patient selection for atrial fibrillation ablation. Low voltage areas in the left atrium predict arrhythmia recurrence when mapped in sinus rhythm. This study tested type III procollagen N terminal peptide (PIIINP), galectin-3 (gal-3), fibroblast growth factor 23 (FGF-23), and type I collagen C terminal telopeptide (ICTP), and whether low voltage areas in the left atrium predicted atrial fibrillation recurrence, irrespective of the rhythm during mapping.92 atrial fibrillation ablation patients were studied. Biomarker levels in peripheral and intra-cardiac blood were measured with enzyme-linked immunosorbent assay. Low voltage (
    • File Description:
      electronic resource
    • ISSN:
      1932-6203
    • Relation:
      http://europepmc.org/articles/PMC5749720?pdf=render; https://doaj.org/toc/1932-6203
    • Accession Number:
      10.1371/journal.pone.0189936
    • Rights:
      Journal Licence: CC BY
    • Accession Number:
      edsdoj.26dc84da9222458c86954a53363d8093
  • Citations
    • ABNT:
      GORDON A BEGG et al. Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study. PLoS ONE, [s. l.], v. 13, n. 1, p. e0189936, 2018. DOI 10.1371/journal.pone.0189936. Disponível em: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsdoj&AN=edsdoj.26dc84da9222458c86954a53363d8093&custid=s8280428. Acesso em: 15 ago. 2020.
    • AMA:
      Gordon A Begg, Rashed Karim, Tobias Oesterlein, et al. Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study. PLoS ONE. 2018;13(1):e0189936. doi:10.1371/journal.pone.0189936
    • APA:
      Gordon A Begg, Rashed Karim, Tobias Oesterlein, Lee N Graham, Andrew J Hogarth, Stephen P Page, Christopher B Pepper, Kawal Rhode, Gregory Y H Lip, Arun V Holden, Sven Plein, & Muzahir H Tayebjee. (2018). Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study. PLoS ONE, 13(1), e0189936. https://doi.org/10.1371/journal.pone.0189936
    • Chicago/Turabian: Author-Date:
      Gordon A Begg, Rashed Karim, Tobias Oesterlein, Lee N Graham, Andrew J Hogarth, Stephen P Page, Christopher B Pepper, et al. 2018. “Left Atrial Voltage, Circulating Biomarkers of Fibrosis, and Atrial Fibrillation Ablation. A Prospective Cohort Study.” PLoS ONE 13 (1): e0189936. doi:10.1371/journal.pone.0189936.
    • Harvard:
      Gordon A Begg et al. (2018) ‘Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study’, PLoS ONE, 13(1), p. e0189936. doi: 10.1371/journal.pone.0189936.
    • Harvard: Australian:
      Gordon A Begg, Rashed Karim, Tobias Oesterlein, Lee N Graham, Andrew J Hogarth, Stephen P Page, Christopher B Pepper, Kawal Rhode, Gregory Y H Lip, Arun V Holden, Sven Plein & Muzahir H Tayebjee 2018, ‘Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study’, PLoS ONE, vol. 13, no. 1, p. e0189936, viewed 15 August 2020, .
    • MLA:
      Gordon A Begg, et al. “Left Atrial Voltage, Circulating Biomarkers of Fibrosis, and Atrial Fibrillation Ablation. A Prospective Cohort Study.” PLoS ONE, vol. 13, no. 1, Jan. 2018, p. e0189936. EBSCOhost, doi:10.1371/journal.pone.0189936.
    • Chicago/Turabian: Humanities:
      Gordon A Begg, Rashed Karim, Tobias Oesterlein, Lee N Graham, Andrew J Hogarth, Stephen P Page, Christopher B Pepper, et al. “Left Atrial Voltage, Circulating Biomarkers of Fibrosis, and Atrial Fibrillation Ablation. A Prospective Cohort Study.” PLoS ONE 13, no. 1 (January 1, 2018): e0189936. doi:10.1371/journal.pone.0189936.
    • Vancouver/ICMJE:
      Gordon A Begg, Rashed Karim, Tobias Oesterlein, Lee N Graham, Andrew J Hogarth, Stephen P Page, et al. Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study. PLoS ONE [Internet]. 2018 Jan 1 [cited 2020 Aug 15];13(1):e0189936. Available from: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsdoj&AN=edsdoj.26dc84da9222458c86954a53363d8093&custid=s8280428